Roche Holding AG (RHHVF)
289.09
-5.79
(-1.96%)
USD |
OTCM |
Nov 14, 16:00
Roche Total Liabilities (Quarterly): 69.98B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 69.98B |
| June 30, 2024 | 69.98B |
| December 31, 2023 | 68.11B |
| June 30, 2023 | 60.08B |
| June 30, 2023 | 60.08B |
| December 31, 2022 | 60.55B |
| June 30, 2022 | 60.55B |
| June 30, 2022 | 60.55B |
| December 31, 2021 | 69.98B |
| June 30, 2021 | 50.44B |
| June 30, 2021 | 50.44B |
| December 31, 2020 | 53.07B |
| June 30, 2020 | 47.89B |
| June 30, 2020 | 47.89B |
| December 31, 2019 | 48.74B |
| June 30, 2019 | 50.34B |
| June 30, 2019 | 50.34B |
| December 31, 2018 | 48.91B |
| June 30, 2018 | 48.13B |
| June 30, 2018 | 48.13B |
| December 31, 2017 | 48.94B |
| June 30, 2017 | 48.73B |
| June 30, 2017 | 48.73B |
| December 31, 2016 | 49.55B |
| June 30, 2016 | 54.54B |
| Date | Value |
|---|---|
| June 30, 2016 | 54.54B |
| December 31, 2015 | 53.08B |
| June 30, 2015 | 53.63B |
| June 30, 2015 | 53.63B |
| December 31, 2014 | 54.59B |
| June 30, 2014 | 47.67B |
| June 30, 2014 | 47.67B |
| December 31, 2013 | 46.12B |
| June 30, 2013 | 45.85B |
| June 30, 2013 | 45.85B |
| December 31, 2012 | 52.64B |
| June 30, 2012 | 49.24B |
| June 30, 2012 | 49.24B |
| December 31, 2011 | 50.05B |
| June 30, 2011 | 53.34B |
| June 30, 2011 | 53.34B |
| December 31, 2010 | 52.80B |
| June 30, 2010 | 51.99B |
| December 31, 2009 | 62.91B |
| June 30, 2009 | 65.63B |
| December 31, 2008 | 20.84B |
| June 30, 2008 | 21.06B |
| June 30, 2008 | 21.06B |
| December 31, 2007 | 21.99B |
| June 30, 2007 | 21.41B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
47.89B
Minimum
Jun 2020
69.98B
Maximum
Dec 2021
58.56B
Average
60.08B
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 135.61M |
| CRISPR Therapeutics AG | 316.47M |
| Addex Therapeutics Ltd | 1.164M |
| NLS Pharmaceutics Ltd | 10.46M |
| Molecular Partners AG | 18.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.56B |
| Shareholders Equity (Quarterly) | 32.20B |
| Debt to Equity Ratio | 1.19 |
| Current Ratio | 1.264 |
| Net Debt Paydown Yield | -1.66% |